# Pancrelipase

## Protase 280mg enteric coated

| TAH Drug Code      | [OPROT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPROT                                               |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------|
| Indications        | Cystic fibrosis, post-pancreatectomy, total gastrectomy, or chronic pancreatitis, ductal obstruction from neoplasm. |
| Dosing             | Adult & children >6 years: Initially 1 CAP with meals. Fibrocyst:1500-3000 USP Lipase Units/kg, with every meals.   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                       |
| Contraindications  | Early stages of acute pancreatitis.                                                                                 |
| Adverse Effects    | Nausea, vomiting, bloating, cramping, constipation or diarrhea.                                                     |
| Pregnancy          | Unknown                                                                                                             |
| Lactation          | Unknown                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/pancrelipase-drug-information)                                         |

